Now new: Reimbursement by health insurance companies for fertility treatment with OvulaRing for women and couples with unfulfilled desire to have children

Lesedauer

ca. 3 Minutes

Datum

Health Insurance Coverage for OvulaRing

Since January 2021, the health insurance providers BIG direkt gesund, HEK – Hanseatische Krankenkasse, IKK Südwest, and mhplus Krankenkasse have been covering up to 12 months of treatment with OvulaRing. These insurers compensate the medical services and cover most of the costs for insured women.

OvulaRing is the first globally recognized digital cycle diagnostic tool that forms the basis for a personalized treatment plan for women struggling with infertility, with costs covered by statutory health insurance.


Background

Developed by gynecologist and reproductive specialist Prof. Henry Alexander and VivoSensMedical, OvulaRing enables individualized cycle diagnostics. Based on this data, a new, personalized fertility treatment approach has been introduced, aiming to increase natural conception rates and reduce the need for costly and stressful fertility treatments.

Thanks to its success in the Healthy Hub 2019 competition, OvulaRing is now part of the primary healthcare market. The Healthy Hub is a contest initiated by five statutory health insurance companies to test innovative digital health solutions.


Patient Contribution & Treatment Duration

12-month coverage by participating health insurance providers
Only €99 patient contribution instead of €480
The rest of the costs are fully covered

This innovative cycle-based fertility treatment is now available to insured women through participating gynecologists.


Eligibility for OvulaRing Coverage

Female, aged 25-39
Insured with BIG direkt gesund, HEK, IKK Südwest, or mhplus Krankenkasse
Married
Trying to conceive for at least six months
No prior or ongoing artificial fertility treatments

A participating gynecologist will confirm eligibility in a consultation. If you don’t fully meet the criteria but are insured with one of the listed providers, contact OvulaRing or your health insurer to explore options.


Your Benefits at a Glance

12 months of OvulaRing cycle diagnostics for only €99
Continuous medical supervision
Detailed insights into your cycle health and personalized treatment options
A hormone-free, side-effect-free medical device


How to Enroll

  1. Schedule an appointment with a participating gynecologist. Contact OvulaRing at info@ovularing.com to find a nearby practice.
  2. Sign a participation agreement provided by your doctor.
  3. Your doctor submits your form, and you receive a discounted OvulaRing package for the first 6 months (€99).
  4. Use OvulaRing to track your cycle at home.
  5. Quarterly medical check-ups (in-person or telemedicine) guide your fertility journey.
  6. After 6 months, your doctor will decide whether to extend coverage for another 6 months (at no additional cost).
  7. If pregnancy occurs or the 12-month period ends, a final consultation is scheduled. If no pregnancy occurs, your fertility data can support a referral to a fertility center.

More details on participation & costs


How Can My Gynecologist Participate?

Doctors can enroll in a selective contract with the insurance provider by contacting OvulaRing via phone, email, or online form. Participating practices receive full support from the OvulaRing team.


What If My Health Insurance Isn’t Listed?

Unfortunately, we cannot guarantee coverage from other providers. However, you can submit a request to your insurer. Many providers consider doctor recommendations, and OvulaRing can provide a cost estimate for your application. Contact info@ovularing.com for assistance.


Switching Health Insurance for OvulaRing Coverage

Health insurance changes are now simpler and faster. Just fill out the membership application on your new insurer’s website. The switch takes effect after two months, and the new provider handles the transition. Contact your chosen insurance provider for details.


Accompanying Study on Cycle Diagnostics

OvulaRing’s partnership with statutory health insurers is supported by the largest study of its kind worldwide, conducted by InGef (Institute for Applied Health Research Berlin GmbH).

Evaluates OvulaRing’s effectiveness in fertility treatments
Scientific analysis of cycle diagnostics
Data is used anonymously

By participating, you contribute to advancing women’s health research.

⚡ Lightning discount - only 48h! Get 12% off our starter packages 6 and 12 with BLITZ12 ⚡zum Shop

Neuste
Beiträge